Overview
This replacement post is for 10 Programmed Activities (PAs) per week to provide oncology management and treatment within the Genito-Urinary (GU) Disease Group. The Clinical Oncologist appointed will work with the GU team to provide a comprehensive clinical service for GU patients in outpatient, inpatient and ambulatory settings, delivering Radiotherapy and Systemic Anti-Cancer Therapy (SACT) whilst also providing Clinical Oncology input to the GU MDT.
Group and services
GU Disease Group led by Professor Ananya Choudhury consists of 11 Clinical Oncologists. These oncologists manage all GU cancers diagnosed within the Greater Manchester and Cheshire Cancer Network, with many delivering a peripheral/Christie @ service through MDTs and clinics. Systemic therapy is delivered centrally or given to patients at peripheral or outreach clinics according to agreed protocols. Radiotherapy is delivered at The Christie or at our satellite units in Salford, Oldham and Macclesfield. The group has an active prostate brachytherapy service, and the team has a strong commitment to research and trial activity in which the appointee would be expected to be involved. Systemic treatment for Germ Cell and renal is provided by the Medical Oncologist at the Christie. All Disease Group consultants work as part of a multi-disciplinary team supporting the delivery of this work including 5 Nurse Clinicians/Advanced Clinical Practitioners (including trainees), 4.8 Clinical Nurse Specialists, 4 Clinical Research Fellows, 4 Specialist Trainees, 1 Pharmacist and 4.5 Research Nurses. The appointee will serve the South Sector MDT which takes referrals from Stockport, Macclesfield and Tameside. The urology group has an established record in radiotherapy related research with an internationally recognized programme of research. Radiotherapy-related research is led by Professor Ananya Choudhury and the urology team have monthly multi-disciplinary radiotherapy research meetings with regular attendance by radiographers, physicists and clinicians. There is also a monthly research seminar at which ongoing research is presented by surgical, radiotherapy and systemic teams. Systemic and novel agent clinical trials are led by Dr A Hudson. The GU clinical oncology group has a broad clinical trial portfolio with phase I/II/III trials delivering research studies to ~150-200 patients per year. The research team comprises 5 experienced research nurses and 6 clinical trials administrators. The appointee will be encouraged to develop a research interest which may include the setting up of radiotherapy trials or clinical developments involving advanced radiotherapy techniques such as SABR, or MR Linac.
About The Christie
The Christie is one of Europe\'s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country. We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years. We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.
#J-18808-Ljbffr